Amount Raised
$16 Million
Round Type
Funding Round
New RochelleBiotechnologyHealth CareInvestors
Description
LinusBio, a leader in precision exposome sequencing, today announced it raised over $16 million in Series A funding to deliver a novel platform that bridges genomics, the environment, and biological response.
Quick answer
LinusBio raised $16 Million in a Funding Round round, dated January 12, 2023. Investors: Sanford Robertson, Gillian Sandler, The David Bellet Family Office, Nicole Shanahan, Divergent Investments, Bow Capital and Great Point Ventures. LinusBio is based in New Rochelle, New York, United States.
- How much did LinusBio raise?
- LinusBio raised $16 Million in a Funding Round round on January 12, 2023.
- Who invested in LinusBio?
- Sanford Robertson, Gillian Sandler, The David Bellet Family Office, Nicole Shanahan, Divergent Investments, Bow Capital and Great Point Ventures are named as investors in this round.
- What does LinusBio do?
- Linus Biotechnology is a patient-centric, breakthrough science, precision exposome medicine company.
- Where is LinusBio based and how big is it?
- LinusBio is based in New Rochelle, New York, United States.
- Who are the decision-makers at LinusBio?
- Fundz holds 1 contact at LinusBio, including the Co-founder & CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as LinusBio that raised within 45 days of this round, from Fundz verified event records.
- Azora Therapeutics, Inc. (DE) raised $62K (Pre-Seed) on February 23, 2023.
- Voyager Therapeutics raised $39M on February 23, 2023.
- Transcend Therapeutics raised an undisclosed amount (Series A) on February 23, 2023.
- ReAlta Life Sciences raised $12M on February 22, 2023.
- Sorrento Therapeutics raised $75M (Funding Round) on February 21, 2023.
- Esperas Pharma raised an undisclosed amount on February 21, 2023.
Who to call at LinusBio, and when
A new round usually means LinusBio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day LinusBio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LinusBio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LinusBio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LinusBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
LinusBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.